Last reviewed · How we verify
Optimal Medical Therapy (OMT) — Competitive Intelligence Brief
phase 3
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Optimal Medical Therapy (OMT) (Optimal Medical Therapy (OMT)) — Charite University, Berlin, Germany. Optimal Medical Therapy (OMT) is a comprehensive, guideline-based treatment approach that combines multiple pharmacological and lifestyle interventions tailored to individual patient characteristics.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Optimal Medical Therapy (OMT) TARGET | Optimal Medical Therapy (OMT) | Charite University, Berlin, Germany | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Optimal Medical Therapy (OMT) CI watch — RSS
- Optimal Medical Therapy (OMT) CI watch — Atom
- Optimal Medical Therapy (OMT) CI watch — JSON
- Optimal Medical Therapy (OMT) alone — RSS
Cite this brief
Drug Landscape (2026). Optimal Medical Therapy (OMT) — Competitive Intelligence Brief. https://druglandscape.com/ci/optimal-medical-therapy-omt. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab